Adaptive Phage Therapeutics named in reporting citing Top 36 Startups Which Could Change the World - CB Insights Research

As stated by Josh Wolfe, co-founder and managing partner at Lux Capital, “the gap between ‘sci-fi’ — that which was once imagined — and ‘sci-fact’ — that which becomes manifest and real — is shrinking.”